ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

NCI RFP Available.

February 18, 2000

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

Cancer Nurses Urged To Take ‘Proactive Stance’ against Budget Cutting

October 16, 1987

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994